Kim, J., Gosnell, J. E. & Roman, S. A. Geographic influences in the global rise of thyroid cancer. Nat. Rev. Endocrinol. 16, 17–29 (2020).
Kieser, S., Zdobnov, E. M. & Trajkovski, M. Comprehensive mouse microbiota genome catalog reveals major difference to its human counterpart. PLoS Comput. Biol. 18, e1009947 (2022).
Article CAS PubMed PubMed Central Google Scholar
Miller, F. W. The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr. Opin. Immunol. 80, 102266 (2023).
Article CAS PubMed Google Scholar
McLeod, D. S. A. & Cooper, D. S. The incidence and prevalence of thyroid autoimmunity. Endocrine 42, 252–265 (2012).
Article CAS PubMed Google Scholar
McGrogan, A., Seaman, H. E., Wright, J. W. & de Vries, C. S. The incidence of autoimmune thyroid disease: a systematic review of the literature. Clin. Endocrinol. 69, 687–696 (2008).
Rayman, M. P. Multiple nutritional factors and thyroid disease, with particular reference to autoimmune thyroid disease. Proc. Nutr. Soc. 78, 34–44 (2019).
Article CAS PubMed Google Scholar
Taylor, P. N. et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat. Rev. Endocrinol. 14, 301–316 (2018).
Pizzato, M. et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 10, 264–272 (2022).
Ferlay, J. et al. Cancer statistics for the year 2020: an overview. Int. J. Cancer https://doi.org/10.1002/ijc.33588 (2021).
Ahn, H. S. et al. Thyroid cancer screening in South Korea increases detection of papillary cancers with no impact on other subtypes or thyroid cancer mortality. Thyroid 26, 1535–1540 (2016).
Henley, S. J. et al. Annual report to the nation on the status of cancer, part I: National cancer statistics. Cancer 126, 2225–2249 (2020).
Furmaniak, J., Sanders, J., Núñez Miguel, R. & Rees Smith, B. Mechanisms of action of TSHR autoantibodies. Horm. Metab. Res. 47, 735–752 (2015).
Article CAS PubMed Google Scholar
Davies, T. F. et al. Graves’ disease. Nat. Rev. Dis. Prim. 6, 52 (2020).
Wang, Y., Fang, S. & Zhou, H. Pathogenic role of Th17 cells in autoimmune thyroid disease and their underlying mechanisms. Best. Pract. Res. Clin. Endocrinol. Metab. 37, 101743 (2023).
Article CAS PubMed Google Scholar
Walsh, J. P. et al. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J. Clin. Endocrinol. Metab. 95, 1095–1104 (2010).
Article CAS PubMed Google Scholar
Weetman, A. P. An update on the pathogenesis of Hashimoto’s thyroiditis. J. Endocrinol. Invest. 44, 883–890 (2021).
Article CAS PubMed Google Scholar
Blekhman, R. et al. Host genetic variation impacts microbiome composition across human body sites. Genome Biol. 16, 191 (2015).
Article PubMed PubMed Central Google Scholar
Lee, H. J., Stefan-Lifshitz, M., Li, C. W. & Tomer, Y. Genetics and epigenetics of autoimmune thyroid diseases: translational implications. Best. Pract. Res. Clin. Endocrinol. Metab. 37, 101661 (2023).
Article CAS PubMed Google Scholar
Lafontaine, N., Wilson, S. G. & Walsh, J. P. DNA methylation in autoimmune thyroid disease. J. Clin. Endocrinol. Metab. 108, 604–613 (2023).
Köhling, H. L., Plummer, S. F., Marchesi, J. R., Davidge, K. S. & Ludgate, M. The microbiota and autoimmunity: their role in thyroid autoimmune diseases. Clin. Immunol. 183, 63–74 (2017).
Hargreaves, C. E. et al. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves’ disease. J. Immunol. 190, 5373–5381 (2013).
Article CAS PubMed Google Scholar
Covelli, D. & Ludgate, M. The thyroid, the eyes and the gut: a possible connection. J. Endocrinol. Invest. 40, 567–576 (2017).
Article CAS PubMed Google Scholar
Vatanen, T. et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165, 1551 (2016).
Article CAS PubMed Google Scholar
Fugazzola, L. Medullary thyroid cancer – an update. Best. Pract. Res. Clin. Endocrinol. Metab. 37, 101655 (2023).
Article CAS PubMed Google Scholar
Hofstra, R. M. et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367, 375–376 (1994).
Article CAS PubMed Google Scholar
Elisei, R. et al. Somatic RET indels in sporadic medullary thyroid cancer: prevalence and response to selpercatinib. J. Clin. Endocrinol. Metab. 107, 2195–2202 (2022).
Nosé, V., Gill, A., Teijeiro, J. M. C., Perren, A. & Erickson, L. Overview of the 2022 WHO classification of familial endocrine tumor syndromes. Endocr. Pathol. 33, 197–227 (2022).
Yehia, L. et al. Longitudinal analysis of cancer risk in children and adults with germline PTEN variants. JAMA Netw. Open. 6, e239705 (2023).
Article PubMed PubMed Central Google Scholar
Baloch, Z. W. et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr. Pathol. 33, 27–63 (2022).
National Cancer Institute. Thyroid: SEER 5-year relative survival rates, 2014-2020. Surveillance, Epidemiology, and End Results Program seer.cancer.gov/statistics-network/explorer/application.html?site=80&data_type=4&graph_type=5&compareBy=sex&chk_sex_3=3&chk_sex_2=2&series=9&race=1&age_range=1&stage=101&advopt_precision=1&advopt_show_ci=on&hdn_view=0&advopt_show_apc=on&advopt_display=2#resultsRegion0 (2024).
Akaishi, J. et al. Prognostic impact of the Turin criteria in poorly differentiated thyroid carcinoma. World J. Surg. 43, 2235–2244 (2019).
Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell 159, 676–690 (2014).
Fagin, J. A., Krishnamoorthy, G. P. & Landa, I. Pathogenesis of cancers derived from thyroid follicular cells. Nat. Rev. Cancer 23, 631–650 (2023).
Article CAS PubMed PubMed Central Google Scholar
Melo, M. et al. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas. J. Clin. Endocrinol. Metab. 99, E754–E765 (2014).
留言 (0)